Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Isotron was a leading international provider of contract sterilization services, primarily serving the medical device, pharmaceutical, and healthcare industries. The company specialized in gamma irradiation, electron beam processing, and ethylene oxide sterilization, providing essential safety validation for a wide range of healthcare products. Headquartered in the United Kingdom, Isotron operated a significant network of facilities across Europe and Asia. In 2007, the company was acquired by Synergy Health for approximately £163 million, and its operations were later integrated into STERIS plc following Synergy's acquisition in 2015. Today, the legacy of Isotron continues as part of STERIS's Applied Sterilization Technologies (AST) division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Isotron.